Abstract:Background Serum CRP levels can predict future risks among patients with stable and unstable angina, but CRP was easy infected by many factor. Increased blood levels of ox-LDL could play a role in these circumstances. However, Combined detection of ox-LDL and CRP for the prediction of the acute coronary syndrome are not known. Methods All of the patients received a coronary angiography owing to complaining of chest pain. The coronary artery disease dianosis and stenosis severity was judged by two independent experts and the patients were accounting Gensini Score. The serum oxLDL and high sensitivity C-reactive protein (hs-CRP) levels were measured using a sandwich ELISA method. The MACEs of documented CAD patients were recorded in the one year follow-up period. SPSS software was chosen to analyse the influence of Oxidised Low Density Lipoprotein and C-reactive protein on the incidence of MACE. Results (1) In acute myocardial infarction patients, ox-LDL and hs-CRP levels were significantly higher than in patients with unstable angina pectoris (p<0.01) or stable angina pectoris patients (p<0.01) or in controls (p<0.01) (acute myocardial infarction, oxLDL 177.5 mmol/l, hs-CRP 21.4 mg/l; unstable angina pectoris, oxLDL 97.5 mmol/l, hs-CRP 6.7 mg/l; stable angina pectoris, oxLDL 62.3 mmol/l, hs-CRP 3.7 mg/l; Control, oxLDL 41.7 mmol/l, hs-CRP 2.7 mg/l). (2) A positive correlation between the serum levels of oxLDL and CRP with the severity in patients with coronary artery disease. (3) Combined use of Oxidised Low Density Lipoprotein and C-reactive protein can predict the severity in patients with acute coronary syndrome and the risk for major adverse cardiac event (MACE) in patients with acute coronary syndrome (p<0.005). Conclusions This study demonstrates that ox-LDL and hs-CRP levels show a significant positive correlation with the severity of acute coronary syndromes. These findings support the hypothesis that ox-LDL and CRP may play a direct role in promoting the inflammatory component of atherosclerosis. The results suggested that combined use of Oxidised Low Density Lipoprotein and C-reactive protein can predict the acute coronary syndrome. The patient with higher level of ox-LDL and CRP suffer from the higher risk of MACE.

Clinical Value of Combined Assay of Serumal Matrix Metalloproteinases-9 and C-reactive Protein in Patients with Coronary Artery Disease

The clinic relevance between acute coronary syndrome and the level of serum matrix metalloproteinase-9

Value of Matrix Metalloproteinase - 9 and Ischemia - Modified Albumin for Diagnosis of Coronary Heart Disease

Clinical significance of serum interleukin-18 (IL-18) and matrix metalloproteinase-(MMP-9) on acute coronary syndrome

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Changes and Implication of Peripheral Blood Levels of Matrix Metalloproteases-9 and C-reactive Protein in Patients with Coronary Artery Disease

The Role of Serum High Sensitive C-reactive Protein and Matrix Metalloproteinase-9 in Risk Stratification of Patients with Acute Coronary Syndrome

Value of MMP-9 in diagnosis and outcome evaluation of ACS patients

[Plasma Matrix Metalloproteinases-2 and -9 Levels Are Elevated in Patients with Acute Coronary Syndrome and Coronary Chronic Total Occlusion].

Relationship between the plasma level of matrix metalloproteinase-9 and structural characteristics of plaques and percutaneous coronary intervention

Plasma Level of Matrix Metalloproteinase-9 in Patients with Acute Coronary Syndrome and Its Percutaneous Coronary Intervention

The clinical role of increase of serum matrix metalioproteinase-8 concentration in patients with acute coronary syndrome

Correlation Between Coronary Atherosclerotic Plaques and MMP2,MMP9 Levels

Relationship of Serum Matrix Metalloproteinase-9 Level and Lipid Profiles in Coronary Heart Disease

E0451 Combined Use of Oxidised Low Density Lipoprotein and C-reactive Protein for the Prediction of the Acute Coronary Syndrome

The clinical application value of serum hs-CRP, IL-1β and Lp-PLA2 in ACS

Clinical Significance of Plasma High Sensitive C-reactive Protein and Matrix Metalloproteinase-9 in Acute Myocardial Infarction

Plasma Levels of Matrix Metalloproteinase-2 and Tissue Inhibitor of Matrix Metalloproteinase-2 and Its Relationship with Acute Coronary Syndrome

Prognostic Value of Highly Sensitive C-Reactive Protein and Plaque Morphology in Coronary Artery Disease in China.

Association of Arterial Elasticity with Serum High Sensitivity C-reactive Protein and Matrix Metalloproteinase-9 in Patients with Coronary Heart Disease

The Clinical Value of the Serum High-sensitivity C-reactive Protein and Cystatin C Level in Coronary Heart Disease Patients